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Croton schiedeanus Schltd (N.V.: “almizclillo”) is a plant used in traditional medicine as an 
antihypertensive in Colombia. It contains flavonoid, diterpenoid and fenilbutanoid metabolites that 
have vasodilatation effects linked to the NO/cGMP pathway. This work aimed to assess the capacity 
of a 96% EtOH extract to prevent the hypertension induced by nitric oxide (NO) deficiency in rats. 
The NO synthase inhibitor L-NAME (10 mg/kg/d, i.p) was administered during five weeks to three 
groups of rats (6–7 animals): C. Schiedeanus (200 mg/kg/d, p.o), enalapril (reference, 10 mg/kg/d, p.o) 
and vehicle (control: olive oil 1 ml/kg/d, p.o). In addition, the blank group received only vehicle. The 
arterial blood pressure (BP) and heart rate (HR) were measured daily for six weeks. After sacrificing the 
animals, the aortic rings were isolated, contraction was triggered with phenylephrine (PE 10-6 M) and 
relaxant responses were achieved with cumulative concentrations of acetylcholine (ACh, 10-10 – 10-4 M). 
L-NAME increased the systolic arterial pressure in the control group, attaining mean values of 131 mm 
Hg at week 5, whereas the C. schiedeanus, enalapril and blank groups maintained blood pressure under 
100 mm Hg. The capacity of PE to contract aortic rings was greater in the C. schiedeanus, enalapril and 
blank groups than in the control group (2157, 2005, 1910 and 1646 mg, respectively). The pEC50 values 
for ACh were as follows: C. Schiedeanus (6.89) >enalapril (6.39) > blank (5.68) > control (5.09). These 
results give support to C. Schiedeanus as a natural antihypertensive source.
Uniterms: Croton schiedeanus/pharmacognosy. Almizelillo/use/hypertension prevention. Nitric oxide/
deficit. Hypertension/prevention. Plant extracts/vasodilatation effects. Medicinal plants.
Croton schiedeanus Schltd (NV: “almizclillo”) é utilizado na medicina tradicional da Colômbia para o 
tratamento da hipertensão arterial. Outras pesquisas demonstraram que a planta tem metabólitos como 
os flavonoides, os diterpenoides e os fenilbutanoides, os quais têm comprovados efeitos vasodilatadores 
vinculados com a via NO/GMPc. O objetivo deste estudo foi avaliar a capacidade do extrato de Croton 
schiedeanus Schltd em EtOH a 96% na prevenção da hipertensão induzida pela deficiência de óxido 
nítrico (NO), em ratos. O inibidor da NO sintetase L-NAME (10 mg/kg/d, ip) foi administrado durante 
cinco semanas em três grupos de ratos (6-7 animais): C. schiedeanus (200 mg/kg/d, v.o.), enalapril 
(referência, 10 mg/kg/d, v.o.) e o veículo (controle: azeite de oliva 1 mL/kg/d, v.o.). O grupo branco 
recebeu somente o veículo. A pressão sanguínea (BP) e a frequência cardíaca (FC) foram medidas 
diariamente em um período de seis semanas. Após o sacrifício, os anéis aórticos foram isolados e 
contraídos, utilizando fenilefrina (PE 10-6 M) e as respostas para a relaxação foram obtidas com doses 
acumulativas de acetilcolina (ACh, 10-10-10-4 M). Os resultados demonstraram que o L-NAME provocou 
incremento significativo da pressão nos ratos do grupo controle, obtendo-se valores médios de 131 mm 
Hg na quinta semana. No entanto, os grupos C. schiedeanus, enalapril e branco mantiveram a pressão 
arterial aos níveis médios iniciais 100 mm Hg. A capacidade da PE para fazer a contração dos anéis da 
aorta foi maior nos grupos C. schiedeanus, enalapril e branco do que no grupo controle (2157, 2005, 
1910 and 1646 mg, respectivamente). Os valores de pCE50 de ACh foram os seguintes: C. schiedeanus 
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(6,89) > enalapril (6,39) > branco (5,68) > controle (5,09). Pode-se afirmar que estes resultados dão 
suporte à C. schiedeanus como fonte natural anti-hipertensiva.
Unitermos: Croton schiedeanus/farmacognosia. Almizelillo/uso/prevenção da hipertensão. Óxido nítrico/
déficit. Hipertensão/prevenção. Extratos vegetais/efeito vasodilatador. Plantas medicinais.
INTRODUCTION
Hypertension or high blood pressure is one of the 
main health issues in the world. If it is not controlled in an 
adequate way it can lead to severe consequences such as 
cardiac failure, renal insufficiency, brain-vascular stroke, 
heart attack and peripheral vascular disease. It is the 
primary and most common risk factor for heart disease, 
stroke and renal disease. One in six people worldwide, or 
nearly one billion, are affected by high blood pressure and 
it is estimated that this number will increase to 1.5 billion 
by 2025 (Kearney et al., 2005). Unlike most diseases, 
high blood pressure does not present any symptoms and is 
therefore called the “silent killer”. High blood pressure is 
prevalent in every part of the world, in every region of any 
nation and in every community (Chockalingam, 2008).
Endothelial dysfunction is one of the main underlying 
pathophysiological alterations in cardiovascular disorders 
like hypertension, coronary artery disease and heart 
failure. Nitric oxide (NO) plays an important role in the 
maintenance of endothelial integrity. If NO it is produced 
continuously in the physiological range it helps to protect 
the endothelium from the challenges that inflammatory 
molecules carry that induce thrombus, atheroma, apoptosis 
and smooth muscle cell proliferation (Mizuno et al., 2010).
Loss of the capacity to produce NO in an individual 
is accompanied by enhanced vulnerability to hypertension 
and related disorders as a result of increased oxidative 
stress in the vessels and myocardium (Taddei et al., 1992; 
Panza et al., 1993; Mason et al., 2006). Reduction in NO 
synthesis or increase in NO degradation leads to a decrease 
in cyclic guanosine monophosphate (cGMP) formation, 
which promotes vasoconstriction responses, platelet 
adhesion and proliferation of vascular smooth-muscle 
cells, favouring vascular hypertrophy and occlusive 
vascular disease (Forte, Copland, 1997).
Pharmacological and non-pharmacological measures 
that protect against endothelia dysfunction help to preserve 
cardiovascular function. Angiotensin converting enzyme 
inhibitors, statins and some beta blocking agents are 
examples of drugs that favour NO production, reduce 
oxidative stress and ameliorate endothelial lesions (Tzemos 
et al., 2001; Tschöpe et al., 2002; Mason et al., 2004).
Among medicinal plants that seem to favour the NO/
cGMP pathway is Croton schiedeanus Schltd, the scientific 
name of a plant known in Colombia as “almizclillo”. 
Infusions made from the leaves of this species are used 
in traditional medicine to treat high blood pressure in 
temperate parts of this country. The vasodilatory effect 
of ethanol extracts of C. schiedeanus has been described 
previously (Guerrero et al., 2001; Guerrero et al., 2002a) 
as well as their major metabolites and relaxant mechanisms 
related to the NO/cGMP pathway (Guerrero et al., 2002b; 
Guerrero et al., 2002c; Correa et al., 2008; Carrón et al., 
2010). However, the capacity of this species to prevent 
hypertension in rats induced by NO deficit has not yet been 
examined in an experimental model.
The aim of this study was to assess the effect of a 
C. schiedeanus ethanol extract upon hypertension induced 
by the NO synthase inhibitor L-NAME (Nω-Nitro-L-
arginine methyl ester hydrochloride) in Wistar rats.
MATERIAL AND METHODS
Extract Preparation
Plant material from C. schiedeanus Schltd was 
collected from the region of Tocaima, Cundinamarca, 
Colombia in June 2011. Its identity was confirmed by 
comparison with a specimen (Code No. COL 432164) 
classified by Dr. Jose Luis Fernandez and kept in the 
Herbarium of Natural Science Institute at the National 
University of Colombia. The aerial part (approx. 12 kg of 
stems and leaves) was dried in an oven with circulating air 
at 40 ºC during 48 hours. The dried up material was ground 
and the resulting powder percolated through dripping with 
96% EtOH. Afterwards, it was filtered and concentrated 
in a rotary evaporator under reduced pressure until it was 
completely dry. For pharmacological trials, the extract was 
suspended in olive oil to a concentration of 200 mg/mL.
Experimentation animals and treatments
Male Wistar rats (27) were raised in colony cages 
and exposed to a 12 h dark/light cycle with controlled 
temperature and moisture (22 ºC, 70%). They were fed a 
normal laboratory diet with free access to water and food. 
Cardiovascular experiments were carried out on rats aged 
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9–11 weeks and weighing 280–320 g. The experimental 
procedure was approved by the institutional ethics 
committee. The animals were supplied by the Bioterium 
of the Pharmacy Department at the National University of 
Colombia, (UNCSB).
Animals were previously acclimated during two 
weeks and then randomly assigned to four treatment 
groups (n=6–7): C. schiedeanus plus L-NAME, enalapril 
plus L-NAME (as reference), vehicle: olive oil plus 
L-NAME (control), and vehicle without L-NAME 
(blank group). The dosage regimen was: C. schiedeanus, 
200 mg/kg/d, p.o. (according to preliminary trials), 
enalapril, 10 mg/kg/d, p.o. and olive oil 0.1 mL/100 g. 
L-NAME, 10 mg/kg, i.p. was administered every 48 h to 
all groups except the blank group from week 1, seven days 
after C. schiedeanus, enalapril and olive oil administration 
had been started (week 0).
Measurement of Indirect blood pressure (IBP) and 
heart rate (HR)
Indirect blood pressure and heart rate were measured 
with a non-invasive method called the “tail cuff device”, 
placing the base of the rat’s tail into the light of an 
ultrasound transducer (Columbus Instruments 0133-002L, 
model 59) capable of capturing the pulse signal and 
blood pressure. When external pressure is generated, the 
intensity of the pulse signal disappears due to the occlusion 
of blood vessels; the signal reappears when occlusion 
is reduced; this phase of the pulse is considered as the 
systolic pressure (Van Vliet et al., 2000). The transducer 
was plugged into a digital analogue Blast (LabTrax WPI) 
in order to visualize the results using specific software 
(DataTrax WPI program).
Aortic ring preparation
Male Wistar rats obtained from each experimental 
group (C.schiedeanus, enalapril, blank and control), 
were anaesthetized with ether and then sacrificed. The 
descending thoracic aorta was dissected and placed in a 
petri dish containing an oxygenated Krebs solution with 
the following composition (mM): NaCl 118.7; KCl 4.7; 
CaCl2 2.5; NaHC03 25.0; MgS04.7H20 1.2; Glucose 11.0 
and ascorbic acid 0.1. The thoracic aorta rings (3–4 mm 
in length) were carefully excised and submerged in Allhin 
organ chambers containing 10 mL of Krebs solution bathing 
medium maintained at 37 ºC, pH between 7.38 and 7.42 ,and 
continuously gassed with a carbogen mixture of 95% O2 and 
5% CO2. About 8–10 rings were obtained from each aorta.
Each ring was introduced inside an isolated organ 
bath containing 10 mL of Krebs solution maintained at 
37 oC with constant carbogenization. The ring was attached 
with two steel hooks, the inferior anchored to the bath and 
the upper connected to an isometric force transducer (Fort 
10/WPI) coupled to an amplification and digital-analogue 
conversion system (Bridge 8/IsoDam, LabDataTrax, WPI) 
for signal analysis in the computer.
A basal tension of 2 g was applied to each preparation 
with a stabilization period of 60–90 min, during which 
the Krebs solution was changed every 10–15 min. Once 
equilibrium was reached, the aortic rings incubated 
in Krebs solution were exposed to 10-6 M FE until the 
contractile response reached a steady tension (approx. 
40 minutes). Afterwards, acetylcholine (ACh) was added 
cumulatively every 30 s (from 10-10 to 10-4 M) in aliquots 
of 0.5 log units of concentration.
Solutions
The following drugs, salts and solutions were used: 
olive oil (Aceitesublime® G. Sensat), enalapril (Enalapril 
5 mg LaFrancol®), Nω-nitro-L-arginine methyl ester, 
phenylephrine (FE), acetylcholine (Ach), propylene 
glycol, citric acid, sodium citrate, potassium chloride, 
magnesium sulphate, potassium hydrogen phosphate, 
EDTA, L-ascorbic acid, sodium chloride, calcium 
chloride, sodium bicarbonate, and glucose (Sigma®).
Statistical and data analysis
All the results are expressed as mean ± standard 
mean error (SME). Analysis of variance was performed 
followed by the minimum significance difference (MSD) 
test to identify groups responsible for differences in blood 
pressure, heart rate and ring contraction, assuming p≤0.05 
as significant. Dose–response curves of isolated aortic rings 
were analysed by a sigmoid curve-fitting analysis to give the 
negative log of the concentration of ACh producing a 50% 
in the maximal relaxant response (pEC50). SPSS® 20 and 
Excel® 2010 programs were used for data analysis.
RESULTS
Effects of C. schiedeanus on systolic arterial 
pressure and heart rate
The mean systolic arterial pressure value at basal 
conditions (week 0) ranged from 99 to 104 mm Hg 
(n=27) without significant differences between groups. 
The increase in arterial pressure induced by L-NAME 
was significant from week 2 to week 5, attaining values 
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of 136 ± 3 mm Hg. C. schiedeanus was able to maintain 
pressure values below 100 mm Hg during all weeks. 
The effect of the reference drug enalapril was similar to 
C.schiedeanus and to the group of rats not exposed to 
L-NAME (blank group) (Figure 1). The basal heart rate 
value was 436±36 ppm. There was a tendency to heart 
rate decrease in the C. schiedeanus and enalapril groups 
that did not attain statistical significance (data not shown).
In vitro aortic ring studies
Stimulation of aortic rings with FE (1x10-6 M) resulted 
in a sustained contraction, greater in the C. schiedeanus, 
enalapril and blank groups than in the control group 
(2157±147, 1910±144, 2005±180 and 1646±146 mg, 
respectively, n=39, p>0.05). Cumulative addition of ACh 
(10-10 – 10-4 M) in rats previously exposed to L-NAME 
and treated with C. schiedeanus caused a greater relaxant 
response that reduced the contraction previously induced 
by FE to 42%. The ACh relaxant response was lower in the 
enalapril and blank groups (33 and 30%, respectively) and 
significantly lower in the control group (rats exposed only 
to L-NAME, 22%, p<0.05) (Figure 2). According to ACh 
pEC50 values, the ACh relaxant potency was as follows: 
C. schiedeanus (6.89) > enalapril (6.39) > blank (5.68) > 
control (5.09) (Table I).
DISCUSSION
This study shows that a C. schiedeanus ethanolic 
extract is able to prevent the hypertension induced by 
L-NAME in Wistar rats and, at the same time, improve the 
vascular relaxant response in isolated aortic rings. Previous 
works had shown the vasorelaxant effects induced by the 
active principles in this species, the flavonoid nature 
of these compounds, the probable synergistic effects 
induced by them and the importance of the NO/cGMP 
pathway in their mechanisms of action (Guerrero et 
FIGURE 1 - Values of systolic blood pressure in Wistar rats treated with: (1) ethanolic extract of C. schiedeanus Schltd 
(200 mg/kg/day, p.o.) plus L-NAME (10 mg/kg, i.p.), (2) enalapril (reference drug, 10 mg/kg/day, p.o.) plus L-NAME 
(10 mg/kg, i.p.), (3) vehicle (control, olive oil 0.1 mL/100 g, p.o.) plus L-NAME (10 mg/kg, i.p.) and (4) vehicle (blank, olive oil 
0.1 mL/100 g, p.o.). Results are expressed as means ± S.E.M. *p<0.05 with respect to the control group.
FIGURE 2 - Cumulative (10-10- 10-4 M) Acetylcholine dose-
response curves in intact aorta rings prepared from Wistar rats 
previously treated with: (1) ethanolic extract of Croton schiedeanus 
Schltd (200 mg/kg/day, p.o.) plus L-NAME (10 mg/kg, 
i.p.), (2) enalapril (reference drug, 10 mg/kg/day, p.o.) plus 
L-NAME (10 mg/kg, i.p.), (3) vehicle (control, olive oil 
0.1 mL/100 g, p.o.) plus L-NAME (10 mg/kg, i.p) and (4) vehicle 
(blank, olive oil 0.1 mL/100 g, p.o.). Results are expressed as 
means ± S.E.M. *p<0.05 with respect to the control group.
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TABLE I - pEC50(-log[EC50]) and % Emax values (% of maximal effect) induced by Ach (10-10- 10-4 M) in isolated aortic rings 
contracted with FE (10-6 M) from Wistar rats previously treated with: (1) ethanolic extract of C. schiedeanus Schltd (200 mg/kg/
day, p.o.) plus L-NAME (10 mg/kg, i.p.), (2) enalapril (reference drug, 10 mg/kg/day, p.o.) plus L-NAME (10 mg/kg, i.p.), (3) 
vehicle (control, olive oil 0.1 mL/100 g, p.o.) plus L-NAME (10 mg/kg, i.p) and (4) vehicle (blank, olive oil 0.1 mL/100 g, p.o.). 
Results are expressed as means, fiducial limits and S.E.M., respectively. *p<0.05 with respect to the control group
Treatment pEC50 % Emax
L-NAME plus C. schiedeanus 6.89 [6.85 – 6.92]* 41.9 ± 2.6*
L-NAME plus enalapril 6.39 [6.37 – 6.41] 33.2 ± 4.6
L-NAME plus vehicle (control) 5.09 [5.00 – 5.18] 22.4 ± 3.2
Vehicle (blank) 5.68 [5.66 – 6.59] 30.4 ± 4.9
al., 2002a; Guerrero et al., 2002b; Carrón et al., 2010). 
However, until now, the antihypertensive effect of this 
species administered p.o, had not been demonstrated in 
an experimental model of hypertension in rats.
The hypertension induced by L-NAME is a very 
useful model in searching for potential new drugs for 
hypertension. Several groups of antihypertensive drugs 
are active in this model, including: angiotensin converting 
enzyme inhibitors, angiotensin receptor blockers, calcium 
channel blockers and some diuretics and beta blocking 
drugs (Jover, Mimran, 2001; García et al., 2006). In 
addition, this model can show a cardio-protective effect 
of drugs against cardiovascular remodelling (Massion, 
Balligand, 2007). This indicates the pivotal role of NO 
in the physiology of the myocardium and vessels and 
the importance that alterations in this metabolite play 
in cardiovascular disorders like hypertension, coronary 
artery disease and heart failure. In fact, drugs that protect 
the myocardium and vessels favouring the effect of nitric 
oxide can reduce the morbidity and mortality of these 
disorders (von Luederand Krum, 2013). It is interesting 
to observe that C. schiedeanus prevents hypertension in 
a manner that is not inferior to the reference drug used in 
this study, enalapril.
The preservation of vascular function obtained with 
C. schiedeanus became apparent examining the effect of 
ACh in isolated aortic rings from Wistar rats previously 
treated with this extract and exposed at the same time to a 
deficit in NO using L-NAME. Whereas the relaxant effect 
of ACh was reduced in control rats, ACh attained a better 
relaxant response in rats treated with C. schiedeanus, 
even better than the reference drug or the group not 
exposed to an NO deficit (blank group). In addition, 
the vascular contractile capacity tended to increase as 
the result of previous treatment with C. schiedeanus, 
as has been seen with polyphenols compounds such as 
quercetin, among others, that increased NO availability 
(Duarte et al., 2001).
The importance of polyphenol compounds for 
preserving cardiovascular function and their link to the NO/
cGMP pathway has recently been reemphasized (Estruch 
et al., 2013; Habauzitand Morand, 2012). This aspect 
could be especially critical at the beginning of endothelia 
dysfunction, before a cascade of pathophysiological events 
that increase the cardiovascular lesion can take place. 
Foods rich in polyphenol compounds, such as coconut 
and tea, improve blood pressure and cholesterol levels, 
reducing endothelial dysfunction and, consequently, 
the predisposition to plaque formation and thrombus 
generation. C. schiedeanus would represent another 
rich source of flavonoid compounds that help to protect 
against disorders related to the progression of endothelial 
dysfunction.
The relation of the active metabolites from C. 
schiedeanus, mainly the flavonoid compounds ayanin, 
quercetin 3,7-dimethyl ether and quercetin 3,7-ethyl ether 
to the NO/cGMP pathway has been described previously 
(Guerrero et al, 2002a; Guerrero et al., 2002b). They seem 
to act in a synergistic fashion, favouring the persistence 
of NO, with the aim that this metabolite can activate the 
cascade of the cGMP pathway that ends in vasodilation 
and thus reduce the inflammatory processes characteristic 
of advanced hypertension, coronary artery disease and 
heart failure.
Although the scavenging properties of polyphenol 
compounds have been extensively studied, there 
is insufficient evidence that these compounds can 
significantly reduce the impact of cardiovascular disorders 
like hypertension, coronary artery disease and heart failure 
once these have been established (Halliwell, 2007). The 
low bioavailability and high metabolic rate of these 
compounds could in part explain the absence of such 
clinical evidence (Hu, 2007). However, although they 
represent an important natural source that could help to 
prevent such disorders, at least in some instances they 
may act as a therapeutic alternative from a natural source 
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(Davison et al., 2010). C. schiedeanus would be one of 
these alternatives.
Isolated aortic rings represent a useful model to 
study potential vasodilator compounds. The aorta is not a 
resistance vessel, like the mesenteric artery, for instance, 
but a conductance vessel, and it is established that 
hypertension is a disorder due to an increase in resistance 
vessel tone. However, it is clear that several groups of 
antihypertensive drugs are active in this model, including: 
inhibitors of angiotensin converting enzyme (Arnal et al., 
1994), angiotensin receptor blocking drugs (Zhang et al., 
1995), beta blocking drugs (Lee et al, 1992) and calcium 
channel antagonists (Polster et al., 1990). Therefore, the 
vasodilation mechanism observed with C. schiedeanus 
in isolated aortic rings show the potential utility of this 
species when a reduction in vascular tone is needed, as in 
the case of hypertension.
CONCLUSION
In conclusion, C. Shiedeanus Schltd prevents 
experimental hypertension induced in rats with nitric 
oxide deficit, improving the endothelium vasodilatation 
response. These results give support to ethno botanic use 
of C. schiedeanus as a natural antihypertensive agent.
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